文献速递炎症性肠病

肠道通透性增加与后续克罗恩病发病相关

Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
PubMed 文献 · Gastroenterology · 2020-08-10

研究纳入1420名克罗恩病患者无症状一级亲属(6-35岁),2008至2015年入组时检测乳果糖/甘露醇尿排泄比值(LMR),随访至2017年。基线LMR异常(>0.03)与随访期间克罗恩病诊断相关(HR 3.03,95%CI 1.64-5.63,P=3.97×10⁻⁴),即使检测距诊断超过3年该关联仍显著(HR 1.62,95%CI 1.051-2.50,P=.029)。结论认为肠道通透性增加与后续克罗恩病发病相关。

要点

  • 基线LMR>0.03者随访期间克罗恩病诊断风险升高(HR 3.03,95%CI 1.64-5.63)。
  • 检测距诊断超过3年时关联仍显著(HR 1.62,95%CI 1.051-2.50,P=.029)。
  • 异常肠道屏障功能可能作为克罗恩病发病风险的生物标志物。

核心结论

  • 肠道通透性增加与后续克罗恩病发病相关,支持肠道屏障功能改变参与发病机制。
  • 异常肠道屏障功能可能作为克罗恩病发病风险的生物标志物。

研究设计与样本

  • 前瞻性研究,纳入1420名克罗恩病患者无症状一级亲属(6-35岁),2008至2015年入组时检测LMR。
  • 随访诊断为克罗恩病至2017年,中位随访7.8年;50例在中位2.7年后发生克罗恩病,1370例至2017年10月仍无症状。
  • 采用Cox比例风险模型评估基线LMR与克罗恩病的时间相关风险。

主要发现

  • 异常LMR(>0.03)与随访期间克罗恩病诊断相关(HR 3.03,95%CI 1.64-5.63,P=3.97×10⁻⁴)。
  • 检测距克罗恩病诊断超过3年时关联仍显著(HR 1.62,95%CI 1.051-2.50,P=.029)。

关键数值与推荐

  • 异常LMR定义为>0.03。

临床怎么用

  • 原文结论认为异常肠道屏障功能可能作为克罗恩病发病风险的生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Increased intestinal permeability has been associated with Crohn's disease (CD), but it is not clear whether it is a cause or result of the disease. We performed a prospective study to determine whether increased intestinal permeability is associated with future development of CD. METHODS: We assessed the intestinal permeability, measured by the urinary fractional excretion of lactulose-to-mannitol ratio (LMR) at recruitment in 1420 asymptomatic first-degree relatives (6-35 years old) of patients with CD (collected from 2008 through 2015). Participants were then followed up for a diagnosis of CD from 2008 to 2017, with a median follow-up time of 7.8 years. We analyzed data from 50 participants who developed CD after a median of 2.7 years during the study period, along with 1370 individuals who remained asymptomatic until October 2017. We used the Cox proportional hazards model to evaluate time-related risk of CD based on the baseline LMR. RESULTS: An abnormal LMR (>0.03) was associated with a diagnosis of CD during the follow-up period (hazard ratio, 3.03; 95% CI, 1.64-5.63; P = 3.97 × 10-4). This association remained significant even when the test was performed more than 3 years before the diagnosis of CD (hazard ratio, 1.62; 95% CI, 1.051-2.50; P = .029). CONCLUSIONS: Increased intestinal permeability is associated with later development of CD; these findings support a model in which altered intestinal barrier function contributes to pathogenesis. Abnormal gut barrier function might serve as a biomarker for risk of CD onset.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Turpin W, Lee SH, Raygoza Garay JA, et al. Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease. Gastroenterology. 2020. PMID: 32791132. doi:10.1053/j.gastro.2020.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。